Nuveen Asset Management Portfolio holdings
Nuveen Asset Management, founded in 1898 by John Nuveen and headquartered in Chicago, Illinois, is a leading global investment manager and subsidiary of TIAA, overseeing hundreds of billions in assets with a focus on fixed income, equities, and sustainable investing. Initially known for municipal bonds, Nuveen has expanded into a broad range of strategies, including mutual funds, ETFs, closed-end funds, and private capital solutions, serving institutional investors, financial advisors, and individuals. The firm emphasizes income-generating investments and ESG (environmental, social, governance) integration, leveraging its deep research capabilities and a century-long legacy in the bond market. With a strong presence in North America and growing international reach, Nuveen blends tradition with innovation to meet diverse client needs in the evolving investment landscape.
Top Buys
| 1 |
Wells Fargo
WFC
|
$520M |
| 2 |
NVIDIA
NVDA
|
$493M |
| 3 |
Sherwin-Williams
SHW
|
$359M |
| 4 |
Carrier Global
CARR
|
$349M |
| 5 |
CSX Corp
CSX
|
$302M |
Top Sells
| 1 |
Apple
AAPL
|
$1.75B |
| 2 |
Alibaba
BABA
|
$899M |
| 3 |
Alphabet (Google) Class C
GOOG
|
$823M |
| 4 |
Intel
INTC
|
$749M |
| 5 |
Linde
LIN
|
$661M |
Sector Composition
| 1 | Technology | 23.81% |
| 2 | Financials | 12.99% |
| 3 | Consumer Discretionary | 12.71% |
| 4 | Healthcare | 12.61% |
| 5 | Communication Services | 10.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SOL
3201
Emeren Group
SOL
$94.9M
| $265K | ﹤0.01% |
+29,100
| New | +$265K |
|
|
DTP
3202
DELISTED
DTE Energy Company 2019 Corporate Units
DTP
| – | – |
0
| – | – |
|
3203
Advent Technologies
ADN
$10.3M
| $263K | ﹤0.01% |
+27,246
| New | +$263K |
|
3204
Neuropace
NPCE
$302M
| $262K | ﹤0.01% |
+11,008
| New | +$262K |
|
|
SGTX
3205
DELISTED
Sigilon Therapeutics, Inc. Common Stock
SGTX
| $261K | ﹤0.01% |
24,363
+11,864
| +95% | +$127K |
|
3206
Biodesix
BDSX
$63.6M
| $258K | ﹤0.01% |
+19,512
| New | +$258K |
|
3207
Lazydays
GORV
$10.6M
| $257K | ﹤0.01% |
+11,683
| New | +$257K |
|
|
LOMA
3208
Loma Negra
LOMA
$1.08B
| $256K | ﹤0.01% |
37,583
-6,000
| -14% | -$40.9K |
|
3209
Vanguard Large-Cap ETF
VV
$44.1B
| $250K | ﹤0.01% |
+1,246
| New | +$250K |
|
|
STON
3210
DELISTED
StoneMor Inc.
STON
| $247K | ﹤0.01% |
+94,382
| New | +$247K |
|
|
AFCG
3211
AFC Gamma
AFCG
$101M
| $237K | ﹤0.01% |
+11,483
| New | +$237K |
|
|
AKYA
3212
DELISTED
Akoya BioSciences
AKYA
| $234K | ﹤0.01% |
+12,101
| New | +$234K |
|
3213
NL Industries
NL
$322M
| $233K | ﹤0.01% |
35,903
+6,975
| +24% | +$45.3K |
|
|
SRGA
3214
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $225K | ﹤0.01% |
162,222
-316,749
| -66% | -$439K |
|
3215
Bioventus
BVS
$483M
| $219K | ﹤0.01% |
12,422
| – | – |
|
3216
Hawthorn Bancshares
HWBK
$226M
| $216K | ﹤0.01% |
+9,426
| New | +$216K |
|
3217
HighPeak Energy
HPK
$990M
| $215K | ﹤0.01% |
+21,015
| New | +$215K |
|
3218
Biomea Fusion
BMEA
$121M
| $214K | ﹤0.01% |
+13,688
| New | +$214K |
|
3219
Werewolf Therapeutics
HOWL
$59.4M
| $209K | ﹤0.01% |
+12,001
| New | +$209K |
|
3220
Tourmaline Bio
TRML
$606M
| $207K | ﹤0.01% |
+14,098
| New | +$207K |
|
3221
Five Star Bancorp
FSBC
$696M
| $202K | ﹤0.01% |
+8,362
| New | +$202K |
|
|
ZEPP
3222
Zepp Health
ZEPP
$696M
| $199K | ﹤0.01% |
16,927
-1,200
| -7% | -$14.1K |
|
3223
Venus Concept
VERO
$4.05M
| $195K | ﹤0.01% |
62,738
-363,273
| -85% | -$1.13M |
|
|
ASPU
3224
DELISTED
ASPEN GROUP, INC.
ASPU
| $192K | ﹤0.01% |
29,461
-32,501
| -52% | -$212K |
|
3225
Mirum Pharmaceuticals
MIRM
$3.73B
| $191K | ﹤0.01% |
11,020
-3,300
| -23% | -$57.2K |
|